In June 2025, a group of 22 large U.S. banks comfortably cleared the Federal Reserve's annual stress test, demonstrating their resilience to a hypothetical severe recession. The regulator stated that these banks would withstand over $550 billion in losses and remain above minimum capital levels, indicating that "large banks are well positioned to weather a severe recession." This outcome paved the way for these financial institutions to boost buybacks and dividends for their shareholders.

Following the stress test results, Wall Street's largest lenders increased their dividends. This year's test was noted for being somewhat less stringent than in previous years, as regulators softened some requirements. Goldman Sachs Group Inc. and Morgan Stanley were among the firms that raised their quarterly payouts after the Fed's annual review, leading shares of both banks to hover near record highs.

While the 2025 stress test led to increased payouts, the 2026 test took an "unusual" turn, with its results not directly impacting the Stress Capital Buffer (SCB) or shareholder returns. This change was tied to a broader review of capital regulations by the Trump administration. The Fed opted to hold capital standards steady through 2027, effectively freezing the binding force of the stress test results for that period. This decision came after the banking industry expressed frustration with the opacity of the review process and, in 2024, sued the Fed, pushing for reforms that would allow banks prior input on the tests.

The 2026 stress test is serving as a crucial gauge of financial system health and a litmus test for the direction of regulatory reform, as the Fed itself is undertaking a fundamental review of the stress test framework. Analysts note that while the results still provide insight into a bank's cushion against a disaster scenario, they no longer directly set capital floors. The focus of the capital debate has shifted to other regulations, such as Basel III endgame and the GSIB surcharge, rather than the immediate impact of the stress test results on capital requirements or payouts.